SNG Stock Up 470%, Synairgen Reports COVID-19 Vaccine Trial Results
Following the company’s announcement about the success of its COVID-19 vaccine, Synairgen stock has increased significantly. Now it is nearly 470% up.British pharmaceutical company Synairgen Plc (LON: SNG) that is taking part in the COVID-19 vaccine race has announced positive results for the trial of its vaccine candidate. According to
Read More